Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2005
07/06/2005CN1633994A Compound control-released percutaneous medicine plaster for treating high blood pressure and its preparation method
07/06/2005CN1633993A Polymer material pharmaceutical preparation capsule releasing under control of outer enviornment pH value
07/06/2005CN1633992A Pharmaceutical drop pills and its preparation method
07/06/2005CN1633991A Granular folacin production method and product
07/06/2005CN1633990A Preparation method of liposome with high encapsulating rate to water soluble medicine
07/06/2005CN1633989A Medicinal sausage for children
07/06/2005CN1633988A Pharmaceutical sausage
07/06/2005CN1633893A Nutritious tablet for female
07/06/2005CN1633889A Liver protecting health food
07/06/2005CN1209188C Dehydrating agent and method for dehydrating method of hydrate using the agent and dehydrated article obtained by the method
07/06/2005CN1209165C Method for cell adhesion and wound healing
07/06/2005CN1209164C Compositions comprising DNA damaging agents and P53
07/06/2005CN1209160C Skin-infiltrating film of Chinese traditional medicine for treating paralysis resulting from central nerve trauma and its preparation method
07/06/2005CN1209157C External applied pedicure ointment
07/06/2005CN1209154C Novel preparation process of Qingkailing injection
07/06/2005CN1209148C Ankangxin capsule
07/06/2005CN1209121C Heart-strengthening and blood circulation-promoting liquid medicine for treating heart diseases and its preparation
07/06/2005CN1209119C Powder for treating eye disease and preparing method thereof
07/06/2005CN1209118C Ointment for treating piles and other anorectal diseases and its preparation
07/06/2005CN1209117C Small pellet of extraction of kudzu vine, and its preparation method
07/06/2005CN1209113C Tincture for treating psoriasis
07/06/2005CN1209109C Slow-releasing acipimox tablet
07/06/2005CN1209108C Trans-dermal composition of anti-vomiting agent and preparation containing the same
07/06/2005CN1209106C Use of ellagic acid as anti-pollution cosmetic agent
07/06/2005CN1209105C Coronary artery skeleton medicinal coating for preventing restenosis of blood vessel
07/06/2005CN1209104C Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method
07/06/2005CN1209103C Fenofibrate soft capsule and its preparation method
07/06/2005CN1209102C Arginine acetate oral preparation and clinical application thereof
07/06/2005CN1209101C Metformin hydrochloride sustained-release tablet and method for preparing the same
07/06/2005CN1209100C Preparation of durable Chinese medicine and healthy food effervescent tablets
07/06/2005CN1209099C Agglomerates by crystallisation
07/06/2005CN1209098C Methods and devices for providing prolonged drug therapy
07/06/2005CN1209091C 硬胶囊 Hard Capsules
07/05/2005US6914169 Can fully be prevented from peeling off when employed in a plaster agent or poultice agent, whereas the rash of skin and the pain upon peeling are suppressed
07/05/2005US6914168 Does not entail dipping a body portion into hot paraffin by applying strip containing the flowable paraffin composition to a portion of skin of the patient
07/05/2005US6914141 Useful as inhibitor of platelet agglomeration
07/05/2005US6914073 Multivitamin/multimineral optimized for cardiovascular health containing increased levels of Vitamin E; does not leach vitamin E
07/05/2005US6914072 E.g., ajulemic acid; used for decreasing cell proliferation
07/05/2005US6914070 Ophthalmic compositions for treating ocular hypertension
07/05/2005US6914055 Cancer therapeutic formulation having reduced toxicity comprising a galactomannan, and a chemotherapeutic agent
07/05/2005US6913877 Using chromogenic agents to identify and quantify neurotransmitters, toxins, hormones and chemical warfare agents
07/05/2005US6913779 Process for the preparation of accelerated release formulations using compressed fluids
07/05/2005US6913768 Attention deficit disorders
07/05/2005US6913767 For aids
07/05/2005US6913766 Preparation consisting of a film, sheet or wafer-shaped form of administration with a two-layered structure and an integrated identification marking
07/05/2005US6913764 Antibiotic(s) preparation with retarding active ingredient release
07/05/2005US6913763 Feedback regulated delivery method and apparatus specifically in the treatment of neurological diseases and chronic pain.
07/05/2005US6913761 Sustained drug delivery
07/05/2005US6913760 Polymer and a pain-relieving combination of an anesthetic agent and an analgesic agent.
07/05/2005US6913759 Gel composition and method for treatment of vaginal infections
07/05/2005US6913615 Chemiluminescent treatment of acne
07/05/2005CA2274910C Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same
07/05/2005CA2264250C Tablet with controlled release of alfuzosin hydrochloride
07/05/2005CA2101101C Skin care compositions comprising a retinoid and an imidazole
07/05/2005CA2093946C Methanediphosphonic acid formulations with ion exchangers
06/2005
06/30/2005WO2005059003A1 Novel polyesters
06/30/2005WO2005058935A2 Aqueous suspensions of ciclesonide for nebulisation
06/30/2005WO2005058480A2 Particle and particle manufacturing method and apparatus
06/30/2005WO2005058474A1 Cryogranulation and storage method for active pharmaceutical agents
06/30/2005WO2005058472A2 Systems for preparing fine particles and other substances
06/30/2005WO2005058385A2 Multiple section parenteral drug delivery apparatus
06/30/2005WO2005058368A1 Methods and compositions for treatment of interferon-resistant tumors
06/30/2005WO2005058365A1 Pharmaceutical preparation containing an antibody for the egf receptor
06/30/2005WO2005058364A2 Preservative system
06/30/2005WO2005058362A2 Method for opening tight junctions comprising the use of jam-1, claudin-4 and occludin protein antagonists as well as sirna molecules
06/30/2005WO2005058356A2 Methods for porducing storage stable viruses and immunogenic compositions thereof
06/30/2005WO2005058354A1 Recombinant vibrio cholerae strain and vaccine comprising said strain
06/30/2005WO2005058340A1 Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
06/30/2005WO2005058332A2 Edestin-comprising agent for substitution of blood plasma and a method of its production
06/30/2005WO2005058329A1 Use of treprostinil to improve kidney functions
06/30/2005WO2005058306A1 Glutamine-containing energy imparting amino acid composition or amino acid solution
06/30/2005WO2005058302A1 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity
06/30/2005WO2005058297A1 Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia
06/30/2005WO2005058294A1 Copper antagonist compounds
06/30/2005WO2005058291A1 Microemulsion preconcentrate comprising a renin inhibitor
06/30/2005WO2005058289A1 A method of preparing intranasal dry powders inhalant of calcitonin
06/30/2005WO2005058288A2 Antimicrobial article with diffusion control layer
06/30/2005WO2005058287A2 Transdermal delivery system of hormones without penetration enhancers
06/30/2005WO2005058286A1 Sustained release torsemide dosage forms
06/30/2005WO2005058285A1 Tablets having an emulsified polymer matrix for the controlled emission of gas, and production process
06/30/2005WO2005058284A2 Fast-disintegrating tablets
06/30/2005WO2005058283A2 Stabilised compositions of factor vii polypeptides
06/30/2005WO2005058282A1 Double pellet formulation of proton pump inhibitors and clarithromycin for the treatment of gastrointestinal ulcer, and method for producing the same
06/30/2005WO2005058281A1 Hydroxysteroid dehydrogenase inhibitors adsorbed on hydrophilic carriers
06/30/2005WO2005058280A2 Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
06/30/2005WO2005058279A1 Biodegradable triblock copolymers as drugs solubilizing agents and method of use
06/30/2005WO2005058278A1 Drug delivery compositions and methods
06/30/2005WO2005058277A1 Injectable composition
06/30/2005WO2005058276A1 Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having goog palatability
06/30/2005WO2005058275A2 Ingestible capsules containing ethanol
06/30/2005WO2005058250A2 Methods of administering water-soluble prodrugs of propofol for extended sedation
06/30/2005WO2005058242A2 Chewable soft capsules containing ungelatinized starch
06/30/2005WO2005058198A1 Therapeutic microparticles
06/30/2005WO2005046316A3 Bovine germicide application device
06/30/2005WO2005041921A3 Dry powder compositions for inhalation therapy comprising calcium stearate, medical devices therefor
06/30/2005WO2005040206A8 Glurp-msp3 fusion protein, immunogenic compositions and malarial vaccines containing it
06/30/2005WO2005037247A3 Oral matrix formulations of doxazosin
06/30/2005WO2005034926A3 Non-invasive system for detecting skin cancer
06/30/2005WO2005034917A3 Hydrophobic silica-based water powder
06/30/2005WO2005032401A3 Pressure-sensitive adhesive sheet for application to skin